UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008215
Receipt number R000009648
Scientific Title Effect of Royal Jelly on muscle strength in free-living elderly people: A randomized controlled study
Date of disclosure of the study information 2012/06/19
Last modified on 2016/03/24 11:48:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Royal Jelly on muscle strength in free-living elderly people: A randomized controlled study

Acronym

Royal Jelly and sarcopenia

Scientific Title

Effect of Royal Jelly on muscle strength in free-living elderly people: A randomized controlled study

Scientific Title:Acronym

Royal Jelly and sarcopenia

Region

Japan Asia(except Japan)


Condition

Condition

Sarcopenia

Classification by specialty

Geriatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effects of Royal Jelly versus placebo on muscle strength in elderly people

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Phase III


Assessment

Primary outcomes

grip strength

Key secondary outcomes

6 minutes walk test


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Control (placebo)

Interventions/Control_2

low-does Royal Jelly (Royal Jelly: 1.2g/d)

Interventions/Control_3

high-does Royal Jelly (Royal Jelly: 4.8g/d)

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

self-independent elderly

Key exclusion criteria

allergic constitution, visual and hearing
impairment, depression, dementia, etc.

Target sample size

180


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Niu Kaijun

Organization

School of Public Health, Tianjin Medical University

Division name

Department of Epidemiology

Zip code


Address

22 Qixiangtai Road, Heping District, Tianjin 300070, China

TEL

+86-13114814477

Email

nkj0809@163.com


Public contact

Name of contact person

1st name
Middle name
Last name Niu Kaijun

Organization

School of Public Health, Tianjin Medical University

Division name

Department of Epidemiology

Zip code


Address

22 Qixiangtai Road, Heping District, Tianjin 300070, China

TEL

+86-13114814477

Homepage URL


Email

nkj0809@163.com


Sponsor or person

Institute

School of Public Health, Tianjin Medical University

Institute

Department

Personal name



Funding Source

Organization

Institute for Bee Products & Health Science

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 06 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

Royal jelly treatment is effective in
preventing muscle strength and bone mass density decline in elder people.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2011 Year 12 Month 01 Day

Date of IRB


Anticipated trial start date

2012 Year 06 Month 01 Day

Last follow-up date

2013 Year 10 Month 10 Day

Date of closure to data entry

2013 Year 10 Month 31 Day

Date trial data considered complete

2013 Year 12 Month 10 Day

Date analysis concluded

2013 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2012 Year 06 Month 19 Day

Last modified on

2016 Year 03 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009648